How Will PMBJP, PLI, and PRIP Transform the Indian Pharma Sector by 2025?
Click to start listening
Synopsis
The Indian pharmaceutical industry is poised for remarkable growth in 2025, driven by innovative government initiatives like PMBJP, PLI, and PRIP. This transformation aims to enhance access to affordable medications, foster research, and position India as a MedTech leader. Discover how these schemes reshape the future of healthcare in the country!
Key Takeaways
- PMBJP establishes over 2,200 Jan Aushadhi Kendras.
- PLI scheme boosts high-value product manufacturing.
- Significant savings for citizens from affordable medications.
- PRIP supports 111 research projects enhancing innovation.
- India solidifies its position as a global MedTech hub.
New Delhi, Jan 6 (NationPress) The Indian pharmaceutical sector in 2025 experienced a significant transformation due to the government's flagship initiative, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), along with the Production Linked Incentive (PLI) and Promotion of Research and Innovation in Pharma Medtech Sector (PRIP), as stated by the government on Tuesday.
As per an official announcement from the Ministry of Chemicals and Fertilisers, the PMBJP led to the establishment of 2,202 Jan Aushadhi Kendras (JAKs) in 2025, bringing the cumulative total to 17,610 since its inception.
These centers, operated through the Pharmaceuticals & Medical Devices Bureau of India (PMBI), offer generic alternatives to branded medications at reasonable rates.
The PMBJP encompasses 2,110 medicines and 315 medical devices and consumables, spanning 29 therapeutic categories such as anti-infectives, anti-diabetics, cardiovascular treatments, anti-cancer drugs, and gastrointestinal medications.
The ministry reported that in the fiscal year 2024-25, the PMBI achieved sales of Rs 2,022.47 crore, resulting in savings of about Rs 8,000 crore for the public.
For the current fiscal year 2025-26, as of November, the PMBI has recorded sales of Rs 1,409.32 crore, leading to savings of around Rs 5,637 crore for citizens.
The PLI Scheme for pharmaceuticals promotes the production of high-value items such as biopharmaceuticals, complex generics, patented and off-patent medications, orphan drugs, and autoimmune therapies.
The statement revealed that it has generated cumulative sales of Rs 3,08,408.60 crore, including Rs 1,98,509.49 crore in exports since its launch up to September 2025.
Additionally, investments totaling Rs 40,294 crore have been made under the scheme by September 2025, surpassing the original target investment of Rs 17,275 crore.
The PLI scheme also contributed to a reduction in import dependency for bulk drugs.
According to the statement, 30% of India's total bulk drug exports and 26.5% of overall formulation exports in FY 2025 were attributed to production under this scheme.
Under the PRIP Scheme, 111 research projects received approval.
Other key initiatives and accomplishments by the ministry in 2025 include the success of the India Medtech Expo 2025, which highlighted the comprehensive MedTech ecosystem in the nation.
This event further solidified India's status as a global hub for MedTech innovation.
Moreover, the National Institutes of Pharmaceutical Education and Research (NIPERs) continue to advance medical education.
The NIPERs have been ranked among the top 30 pharmacy institutions in India, with 40 faculty members listed in the prestigious Stanford Top 2% Scientists List.
Point of View
It is evident that the government's initiatives are not just mere policy changes but significant steps towards enhancing public health and economic growth. The substantial investments in the pharma sector reflect a commitment to innovation and affordability, aligning with national interests to position India as a leader in pharmaceutical production.
NationPress
07/01/2026
Frequently Asked Questions
What is the PMBJP scheme?
The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) aims to provide affordable generic medicines through Jan Aushadhi Kendras.
How does the PLI scheme benefit the pharma sector?
The Production Linked Incentive (PLI) scheme encourages domestic manufacturing of high-value pharmaceutical products, enhancing exports and reducing import dependence.
What is the significance of the PRIP scheme?
The Promotion of Research and Innovation in Pharma Medtech Sector (PRIP) scheme supports research projects to foster innovation in the medical technology field.
How does PMBJP affect medicine prices?
By providing generic alternatives, PMBJP significantly reduces the costs of medicines for consumers, saving billions annually.
What achievements has the pharma sector made in 2025?
In 2025, the Indian pharma sector saw major advancements including the opening of new Jan Aushadhi Kendras and successful sales figures that reflect significant savings for the public.
